Sec. 199. "Legend drug", for purposes of IC 16-42, means a drug that is:
(1) subject to 21 U.S.C. 353(b)(1);
(2) listed in the Prescription Drug Product List as:
(A) published in United States Department of Health and Human Services Approved Drug Products with Therapeutic Equivalence Evaluations, Tenth Edition, (1990); and
(B) revised in United State Department of Health and Human Services, Approved Drug Products with Therapeutic Equivalence Evaluations, Cumulative Supplement to the Tenth Edition, Number 10 (1990); or
(3) insulin.
[Pre-1993 Recodification Citations: 16-6-8-2(k); 16-6-12-3.]
As added by P.L.2-1993, SEC.1. Amended by P.L.131-2014, SEC.6.